Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Case series:Nil
Sponsors
Wuhan 3rd Hospital
Eligibility
Sex/Gender
All
Age
30 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Confirmed case: any one of the epidemiological history, and in line with the two clinical manifestations, with one of the following etiological evidence: (1) epidemiological history: 1) travel history or residence history of wuhan and surrounding areas or other communities with reported cases within 14 days before onset; 2) within 14 days prior to onset, the patient had been exposed to fever or respiratory symptoms from wuhan city and surrounding areas, or from communities with reported cases; 3) cluster disease; 4) a history of contact with a new type of coronavirus infection (positive in the detection of pathogen nucleic acid); (2) clinical manifestations: 1) fever and/or respiratory symptoms; 2) the total number of white blood cells in the early stage of the disease is normal or decreased, or the lymphocyte count is reduced; (3) pathogenic evidence: 1) real-time fluorescence rt-pcr detection of positive nucleic acid of novel coronavirus in respiratory tract or blood samples; 2) the gene sequencing of the respiratory or blood specimen virus is highly homologous to the known novel coronavirus; 2. Suspected cases: any one of them has an epidemiological history and conforms to any three of the clinical manifestations; (1) epidemiological history: 1) travel history or residence history of wuhan and surrounding areas or other communities with reported cases within 14 days before onset; 2) within 14 days prior to onset, the patient had been exposed to fever or respiratory symptoms from wuhan city and surrounding areas, or from communities with reported cases; 3) cluster disease; 4) a history of contact with a new type of coronavirus infection (positive in the detection of pathogen nucleic acid). (2) clinical manifestations: 1) fever and/or respiratory symptoms; 2) imaging features of the above pneumonia; 3) the total number of white blood cells in the early stage of the disease was normal or decreased, or the lymphocyte count was decreased.
Exclusion criteria
Exclusion criteria: Missing clinical data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| blood biochemistry; | — |
Countries
China
Contacts
Public ContactWang Hua-bing
Wuhan 3rd Hospital
Outcome results
None listed